Oxford Immunotec Global plc (Nasdaq: OXFD)

https://www.oxfordimmunotec.com

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company’s first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company’s second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Also obtained through the acquisitions is the Company’s third product line focused on screening for Babesia in donated blood, for which the Company is currently seeking FDA licensure. The T-SPOT.CMV test and the T-SPOT.PRT test are pipeline products as part of the Company’s fourth intended product line focused on the transplantation market. In addition to these four product lines, the Company has additional active development programs in other immune-regulated conditions. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. *

	Start	2013-11-22 existent
	Group	Oxford Immunotec (Group)
	Industry	diagnostics (medical/biological)
	Person	Wrighton-Smith, Peter (Oxford Immunotec 200508 CEO)

	Region	Abingdon, Oxfordshire
	Country	United Kingdom (GB)
	Street	115D Innovation Drive Milton Park
	City	OX14 4RZ Abingdon, Oxfordshire
	Tel	+44-1235-442-780
		Address record changed: 2020-12-02

Basic data	Employees	D: 101 to 500 (2020-09-30)
	Currency	USD
	Annual sales	62,800,000 (revenue, total (2015) 2015-12-31)
	Profit	-24,500,000 (2015-12-31)
	Cash	83,700,000 (2015-12-31)

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for Oxford Immunotec (Group)

[1] PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com